AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

Although several studies have assessed the effect of non‐vitamin K antagonist oral
anticoagulants (NOACs) relative to that of vitamin K antagonists (VKAs) in patients with left …

Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …

BACKGROUND: Among patients hospitalized for atrial fibrillation, the frequency of off-label
direct oral anticoagulant (DOAC) dosing, associated factors, hospital-level variation, and …

Pulmonary embolism (PE) and deep vein thrombosis are the main clinical manifestations of
venous thromboembolism (VTE). Acute PE is the third most common acute cardiovascular …

Introduction Among patients hospitalized for atrial fibrillation (AF), the frequency of off-label
direct oral anticoagulant (DOAC) dosing, associated factors, hospital-level variation, and …

Background: Current guidelines recommend vitamin K antagonist (VKA) for left ventricular
(LV) thrombus. This study aimed to compare the effectiveness and safety of direct oral …

目的: 探讨与分析经食管实时三维超声心动图评价房颤患者左心耳(LAA) 功能及其与血栓形成的
相关性. 方法: 选择2021 年1 月1 日-2022 年8 月1 日在内蒙古科技大学包头医学院第二附属 …

Devido à escassez de dados, o uso de medicamentos off-label se tornou uma opção
recorrente de tratamento para o público infantil, principalmente na área das doenças …

Controversies and updates in management of atrial fibrillation Logo Image Journal of
BMANA Home (current) About Editorial Board Issues Current Issue Archives Online First …